Drugs / Diprosalic
last change May 2009 re-read 2 minutes ago

Diprosalic

Developed for
psoriasis
Investigated by
LEO Pharma

Trials 1 · a red edge is where a trial was stopped

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00845481 Jan → Mar 2009 psoriasis LEO Pharma Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Diprosalic ClinicalTrials.gov intervention name — accepted as the source's own label NCT00845481
Route Topical “for Topical Use” NCT00845481